Omeros Corporation (OMER) key performance indicators and operating metrics (8 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| YARTEMLEA Gross Revenue | 32.2M | FY2026-Q2 |
| YARTEMLEA Net Revenue | 28.5M | FY2026-Q2 |
| Non-GAAP Adjusted Net Income | 1.8M | FY2026-Q2 |
| Common Stock Shares Repurchased | 500K | FY2026-Q2 |
| Share Repurchase Aggregate Purchase Price | 5.7M | FY2026-Q2 |
| Royalties On Sales Of YARTEMLEA revenue | 300K | FY2026-Q2 |
| Amidria Mid-Year Royalties | 9.2M | FY2025-Q4 |
| Rayner United States Net Sales of Omidria | 30.7M | FY2025-Q4 |
Back to OMER overview · OMER earnings · OMER holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.